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Introduction
Anaerobic infections in the ﬁeld of urology can be roughly
divided into three types: (1) Fournier’s gangrene (Four-
nier’s syndrome), (2) surgical site infections (SSI) after
urinary diversion procedures using the intestine, intraperi-
toneal infections and (3) bacteremia following transrectal




Fournier’s gangrene (Fournier’s syndrome) is fulminant
necrotizing fasciitis (gangrenous fasciitis) developing in an
electroshock manner in the pubis. Without early appro-
priate surgical treatment and antimicrobial chemotherapy,
Fournier’s gangrene can take a fatal course.
This disease has been regarded as a condition which
involves anaerobes more frequently than any other uro-
genital disease. However, depending on culture conditions,
attempts to isolate anaerobes may fail in many cases. It
often assumes the form of a mixed infection. It is not
uncommon for E. coli and other bacteria of Enterobacte-
riaceae to be isolated simultaneously. Stated concretely,
this disease is attributable to mixed infection involving
bacteria as diverse as Escherichia coli, Staphylococcus
aureus, Streptococcus spp., Pseudomonas aeruginosa,
Bacteroides spp., Enterococcus spp., Klebsiella spp.,
Clostridium spp., and Candida spp. Although some
investigators have reported that anaerobes were detected in
only 29% of all cases with Fournier’s gangrene, it seems
likely that this anaerobe detection rate is artiﬁcially low for
reasons such as problems with sample processing, the need
for special anaerobe culture methods, and so on.
Fournier’s gangrene was ﬁrst reported in 1883 by
Fournier, who presented 5 young males who had suddenly
developed this disease, rapidly progressing to gangrene of
the penis and scrotum. Later, this disease was named
‘‘Fournier’s gangrene’’, a severe and necrotizing type of
fasciitis seen in all age groups and even, although rarely, in
women. Fournier’s gangrene affects the genital system
because of the anatomical feature that the subcutaneous
tissue of this area assumes a layered structure and has a
poor in blood supply, often making this area unclean.
Rapid spread of the infection can be explained as follows.
Infection by aerobes lowers the local redox potential,
which stimulates the proliferation of anaerobes. The
resulting obstructive endarteritis stimulates platelet aggre-
gation, which leads to thrombus formation in subcutaneous
vessels, and ﬁnally to necrosis of skin and subcutaneous
tissue and even fascia of the affected area. The most
important factor underlying this condition is diabetes
mellitus. Other underlying factors include alcoholic hepa-
topathy, local trauma, malignant tumors, urinary tract
infection, post-operation, diagnostic procedures, and so on.
Particular care of Fournier’s gangrene is needed in cases
who have undergone urogenital manipulations (transrectal
needle biopsy of the prostate, tension free vaginal tape
(TVT) surgery for female stress urinary incontinence, or
surgery with urethral bougie) (Table 1).
Invasion by bacteria responsible for this disease can take
place via 3 routes: invasion into subcutaneous tissues after
injury, invasion from periurethral glands, and invasion
from the perianal region. Fournier’s gangrene is most likely
to follow a severe course if bacterial invasion has taken
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place via the perianal route. With this route, bacteria break
though the urogenital septum and are likely to reach the
area around the urinary bladder and retroperitoneal cavity.
Initial symptoms of Fournier’s gangrene are erythema,
swelling, pain, etc. of the scrotum, perineum and penis.
These symptoms are later accompanied by fever and chill.
The erythematous area gradually darkens, producing a
putrid odor. In cases in which this disease is caused by gas-
producing bacteria, ﬁne crackles, snow ball crepitation and
signs of gas pooling on plain X-ray are noted. If advanced,
this disease leads to septic shock, DIC and multiple organ
failure. It is not rare for patients with this disease to die
having shown no responses to endotoxin adsorption ther-
apy. Kawanishi et al. reported that of their 70 patients with
severe infection complicated by diabetes mellitus, 10 had
fasciitis and 5 of these 10 had Fournier’s gangrene.
Therefore, when dealing with patients suspected of having
this disease, it is essential not only to subject the pus and
tissue samples to anaerobic culture but also to perform
gram-staining of the sample to assess the possibility of
anaerobic infection and predict the pathogen before con-
ducting the culture test.
Urgent debridement and antimicrobial agents therapy
are used for the treatment of Fournier’s gangrene. When
performing debridement, it is essential, from the beginning,
to perform the manipulation encompassing a wide area. An
aqueous solution of hydrogen peroxide is often used to
clean the wound. In cases in which infection seems likely
to spread into the peritoneal cavity, debridement should be
accompanied by colostomy.
SSI and intraperitoneal infection after urinary diversion
using the intestine
The incidence of SSI is very high rate among patients having
undergone urinary diversion procedures making use of
the intestine. Diverse bacteria can cause SSI. Bacteria
often revealed by culture of samples from these cases are
Enterococcus spp., E. coli, Klebsiella pneumoniae, etc.
However, when smears of the intestinal mucosa, collected at
the time of opening the intestine during surgery, are cultured,
anaerobes (such as Bacteroides and Clostridium spp.) are
often isolated togetherwith the aforementioned aerobes spp.,
and the frequency of isolation is particularly high for Bac-
teroides spp. Therefore, when dealing with cases suspected
of having SSI, it is necessary to consider the possible
involvement of anaerobes (including the possibility of deep
infections causing intraperitoneal abscesses).
Bacteremia and sepsis following transrectal needle
biopsy of the prostate
Transrectal needle biopsy of the prostate can induce pros-
tatitis, bacteremia and sepsis due to intestinal indigenous
bacteria. Anaerobes are occasionally involved in these
conditions. Cases of fatal sepsis due to Clostridium spp.
have also been reported, underscoring the importance of
adequate care. When performing this type of needle biopsy,
it should be borne in mind that the development of pros-
tatitis or sepsis in 1–2% of all cases is inevitable even when
patients receiving this test are given prophylactic antimi-
crobial agents (i.e., high doses of ﬂuoroquinolones). It is
advisable that individual patients be closely monitored for
early detection of infection after this test; individual
patients should be advised to keep records of fever and
urination for several days. These records, kept after the
test, are based informed consent (including delivery of a
diary documenting fevers). Upon the onset of fever after
this test, cultures (urinary and blood) should be performed,
promptly followed by appropriate antimicrobial chemo-
therapy and systemic management (anti-shock therapy,
DIC therapy, etc.). Endotoxin adsorption therapy should
also be administered, as needed.
Selection of antimicrobial agents and how to use them
Drugs to which anaerobes such as Bacteroides spp. are most
susceptible are penicillins, injected with b-lactamase inhib-
itors, and carbapenems. Because clindamycin (CLDM)-
resistant strains (MIC90[ 128 lg/mL) have been increasing
among bacteria of the B. fragilis group, it is advisable to use
carbapenem injections even in the early stages of treatment
when dealing with cases having or suspected of having a
severe anaerobic infection. In cases in which anaerobic
infection is mild to moderate, oxacephems and so on are
suitable. In cases having abscess-forming mixed infections
with aerobes and anaerobes, the infected focus is usually
acidic. According to a report evaluating drug activities
against the B. fragilis group in acidic environments in vitro,
the antimicrobial activity of tazobactam/piperacillin (TAZ/
PIPC) and meropenem (MEPM) remained essentially unaf-
fected by pH.
Table 1 Causes of perineal gangrenous fasciitis
1. Anal diseases (hemorrhoids, anal ﬁstula, perianal abscess, etc.)
2. Urological tests and transurethral manipulations (cystoscopy,
transrectal needle biopsy of the prostate, urethral bougie, etc.)
3. Urogenital infection (prostatitis, epididymitis, etc.)
4. Trauma and dermatitis of the perineum, inguinal region, etc.
5. Surgery for stress incontinence (foreign object insertion)
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